Azitra, Inc. Cash and Restricted Cash
Azitra, Inc. (AZTR) had Cash and Restricted Cash of $6.73 million as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-08-12
- 2026-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $6.73M.
- 2026-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $10.05M.
- 2025-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $2.07M.
- 2025-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $1.40M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents as first filed |
|---|---|---|
| 2026-06-30 | $6.73M 10-Q · filed 2026-08-12 | |
| 2026-03-31 | $10.05M 10-Q · filed 2026-05-13 | |
| 2025-12-31 | $2.07M 10-Q · filed 2026-08-12 | |
| 2025-09-30 | $1.40M 10-Q · filed 2025-11-12 | |
| 2025-06-30 | $1.05M 10-Q · filed 2026-08-12 | |
| 2025-03-31 | $3.21M 10-Q · filed 2026-05-13 | |
| 2024-12-31 | $4.55M 10-Q · filed 2026-08-12 | |
| 2024-09-30 | $7.26M 10-Q · filed 2025-11-12 | |
| 2024-06-30 | $803.08K 10-Q · filed 2025-08-11 | |
| 2024-03-31 | $3.00M 10-Q · filed 2025-05-13 | $3.00M 10-Q · filed 2024-05-09 |
| 2023-12-31 | $1.80M 10-K · filed 2026-02-27 | |
| 2023-09-30 | $4.40M 10-Q · filed 2024-11-12 | |
| 2023-06-30 | $6.29M 10-Q · filed 2024-08-12 | |
| 2023-03-31 | $1.83M 10-Q · filed 2024-05-09 | |
| 2022-12-31 | $3.49M 10-K · filed 2025-02-24 | |
| 2022-09-30 | $5.94M 10-Q · filed 2023-11-14 | |
| 2022-06-30 | $3.75M 10-Q · filed 2023-08-14 | |
| 2021-12-31 | $8.04M 10-K · filed 2024-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |